What does this research mean for the field?

Hospital pharmacists represent a valuable but underutilized resource in clinical research, particularly in Poland, where systemic barriers such as staffing and time constraints currently limit their practical involvement despite their professional readiness. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To examine the expanding clinical and research responsibilities of hospital pharmacists in clinical trials and identify barriers to their integration within multidisciplinary research teams.

September 14, 2026SafetyOpen Access

The Evolving Role of Hospital Pharmacists in Clinical Trials: A Narrative Review and Commentary from a Polish Perspective

View Full Paper

Ask AI

Bookmark

Authors

WJWitold JuchaKrakow Cardiovascular Research Institute ARAnna RapaczJagiellonian University

Discussion

Member takes

Implication

Narrative review reveals expanding clinical trial responsibilities for hospital pharmacists, highlighting ongoing barriers to routine integration and formal outcome evaluation.

Key Points

To examine the expanding clinical and research responsibilities of hospital pharmacists in clinical trials and identify barriers to their integration within multidisciplinary research teams.
Conducted a narrative review and commentary analyzing 27 published sources evaluating pharmacist contributions to clinical research and investigational drug handling.
Hospital pharmacists support investigational medicinal product management, pharmacovigilance, drug-interaction screening, blinding maintenance, and advanced therapy medicinal product logistics.
Available published evidence remains insufficient to draw definitive conclusions regarding pharmacist impact on clinical endpoints, medication-error rates, patient recruitment, or trial adherence.
Key implementation barriers include baseline staffing constraints, organizational limitations, and an absence of protected research time.

Cite This Study

Jucha et al. (2026) studied this question.

synapsesocial.com/papers/6aa7b3580926e14a848b22ca https://doi.org/10.3390/safety12050115

View Full Paper

Ask AI

Bookmark

September 14, 2026SafetyOpen Access

The Evolving Role of Hospital Pharmacists in Clinical Trials: A Narrative Review and Commentary from a Polish Perspective

View Full Paper

Ask AI

Bookmark

Authors

WJWitold JuchaKrakow Cardiovascular Research Institute ARAnna RapaczJagiellonian University

Discussion

Member takes

Implication

Narrative review reveals expanding clinical trial responsibilities for hospital pharmacists, highlighting ongoing barriers to routine integration and formal outcome evaluation.

Key Points

To examine the expanding clinical and research responsibilities of hospital pharmacists in clinical trials and identify barriers to their integration within multidisciplinary research teams.
Conducted a narrative review and commentary analyzing 27 published sources evaluating pharmacist contributions to clinical research and investigational drug handling.
Hospital pharmacists support investigational medicinal product management, pharmacovigilance, drug-interaction screening, blinding maintenance, and advanced therapy medicinal product logistics.
Available published evidence remains insufficient to draw definitive conclusions regarding pharmacist impact on clinical endpoints, medication-error rates, patient recruitment, or trial adherence.
Key implementation barriers include baseline staffing constraints, organizational limitations, and an absence of protected research time.

Cite This Study

Jucha et al. (2026) studied this question.

synapsesocial.com/papers/6aa7b3580926e14a848b22ca https://doi.org/10.3390/safety12050115

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark